| Literature DB >> 17977495 |
Abstract
OBJECTIVE: To provide a teratology update for prescription and non-prescription drugs and infections during pregnancy. OPTIONS: Limited to teratology principles and possible common exposures during pregnancy. EVIDENCE: A search of Medline and textbooks was conducted for information published to June 2006 on teratology exposure risks. This document represents an abstraction of the information. BENEFITS, HARMS, AND COSTS: This consensus provides practitioners with a summary of information regarding teratology risks for drug, chemical, and infection exposures during pregnancy.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17977495 DOI： 10.1016/S1701-2163(16)32668-8
Source DB: PubMed Journal: J Obstet Gynaecol Can ISSN： 1701-2163